{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:26:46Z","timestamp":1783042006217,"version":"3.54.6"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006200","name":"Funda\u00e7\u00e3o Universit\u00e1ria Jos\u00e9 Bonif\u00e1cio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016235","name":"Instituto Nacional de Ci\u00eancia e Tecnologia Midas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016235","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.ejphar.2013.01.050","type":"journal-article","created":{"date-parts":[[2013,2,8]],"date-time":"2013-02-08T16:32:28Z","timestamp":1360341148000},"page":"316-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["A novel Ca\u00b2+ channel antagonist reverses cardiac hypertrophy and pulmonary arteriolar remodeling in experimental pulmonary hypertension"],"prefix":"10.1016","volume":"702","author":[{"given":"Sharlene Lopes","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur Eugen","family":"Kummerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto Manssour","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer Jesus","family":"Barreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazareth de Novaes","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuelle Baptista","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Hamilton Matheus do","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Takashi","family":"Sudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele","family":"Zapata-Sudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2013.01.050_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1476-5381.2010.01164.x","article-title":"New perspectives for the treatment of pulmonary hypertension","volume":"163","author":"Baliga","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.01.050_bib2","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1073\/pnas.86.7.2388","article-title":"Ca2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells","volume":"86","author":"Block","year":"1989","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2013.01.050_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharmthera.2007.03.014","article-title":"Potassium channel diversity in the pulmonary arteries and pulmonary veins: implications for regulation of the pulmonary vasculature in health and during pulmonary hypertension","volume":"115","author":"Bonnet","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2013.01.050_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199207093270202","article-title":"An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension","volume":"327","author":"Christman","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2013.01.050_bib5","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1378\/chest.114.3_Supplement.208S","article-title":"Nitric oxide and endothelin-1 in pulmonary hypertension","volume":"114","author":"Giaid","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2013.01.050_bib6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/385260a0","article-title":"Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression","volume":"385","author":"Hardingham","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2013.01.050_bib7","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1111\/j.1476-5381.1995.tb14960.x","article-title":"Mechanism of action of the inhibitory effect of nifedipine on the growth of cultured aortic cells from spontaneously hypertensive and normotensive rats","volume":"114","author":"Herembert","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.01.050_bib8","doi-asserted-by":"crossref","first-page":"L915","DOI":"10.1152\/ajplung.90286.2008","article-title":"Upregulation of vascular calcium channels in neonatal piglets with hypoxia-induced pulmonary hypertension","volume":"295","author":"Hirenallur","year":"2008","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ejphar.2013.01.050_bib9","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMra040291","article-title":"Treatment of pulmonary arterial hypertension","volume":"35","author":"Humbert","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2013.01.050_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1442-200X.1993.tb03052.x","article-title":"The effect of nifedipine on monocrotaline-induced pulmonary hypertension in rats","volume":"35","author":"Inoue","year":"1993","journal-title":"Acta Paediatr. Jpn."},{"key":"10.1016\/j.ejphar.2013.01.050_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/01.HYP.35.1.173","article-title":"Ion channels and vascular tone","volume":"35","author":"Jackson","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2013.01.050_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(01)00157-7","article-title":"Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension","volume":"92","author":"Jeffery","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2013.01.050_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ejphar.2008.06.001","article-title":"Comparison of the involvement of protein kinase C in agonist-induced contractions in mouse aorta and corpus cavernosum","volume":"590","author":"Jin","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.01.050_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0031-6997(24)01321-8","article-title":"Calcium movements, distribution, and functions in smooth muscle","volume":"49","author":"Karaki","year":"1997","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2013.01.050_bib15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/01.STR.28.2.364","article-title":"Inhibition of PDGF-mediated proliferation of vascular smooth muscle cells by calcium antagonists","volume":"28","author":"Kataoka","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2013.01.050_bib16","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/00004872-199311000-00003","article-title":"Action of dihydropyridine calcium antagonists on early growth response gene expression and cell growth in vascular smooth muscle cells","volume":"11","author":"Ko","year":"1993","journal-title":"J. Hypertension"},{"key":"10.1016\/j.ejphar.2013.01.050_bib17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10554-010-9596-1","article-title":"A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat model","volume":"26","author":"Koskenvuo","year":"2010","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"10.1016\/j.ejphar.2013.01.050_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euje.2005.12.014","article-title":"Recommendations for chamber quantification","volume":"7","author":"Lang","year":"2006","journal-title":"Eur. J. Echocardiogr."},{"key":"10.1016\/j.ejphar.2013.01.050_bib19","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1152\/japplphysiol.00237.2001","article-title":"Therapeutic effects of DCDDP, a calcium channel blocker, on chronic pulmonary hypertension in rat","volume":"92","author":"Li","year":"2002","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2013.01.050_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0143-4160(03)00050-2","article-title":"Retrograde activation of store-operated calcium channel","volume":"33","author":"Ma","year":"2003","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ejphar.2013.01.050_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ahj.2009.11.028","article-title":"Systematic review of trials using vasodilators in pulmonary arterial hypertension: why a new approach is needed","volume":"159","author":"Macchia","year":"2010","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2013.01.050_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1537-1891(02)00123-4","article-title":"Role of K+ channels in pulmonary hypertension","volume":"38","author":"Mandegar","year":"2002","journal-title":"Vas. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.01.050_bib23","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1440-1681.2007.04618.x","article-title":"Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering","volume":"34","author":"Mawatari","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2013.01.050_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjp.0704468","article-title":"The developing relationship between receptor-operated and store-operated calcium channels in smooth muscle","volume":"135","author":"McFadzean","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.01.050_bib25","first-page":"375","article-title":"Nitrendipine attenuates the pulmonary vascular remodeling and right ventricular hypertrophy caused by intermittent hypoxia in rats","volume":"133","author":"Michael","year":"1986","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ejphar.2013.01.050_bib26","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jacc.2009.04.018","article-title":"Cellular and molecular basis of pulmonary arterial hypertension","volume":"54","author":"Morrell","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2013.01.050_bib27","unstructured":"Pereira, S.L., Kummerle, A.E., Fraga, C.A.M., Barreiro, E.J., Sudo, R.T., Zapata-Sudo, G., Vasodilator and antihypertensive effects of a novel N-acylhydrazone derivative mediated by the inhibition of L-type Ca2+ channels. Fundam. Clin. Pharmacol, 10.1111\/j.1472-8206.2012.01076.x, in press"},{"key":"10.1016\/j.ejphar.2013.01.050_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM199701093360207","article-title":"Primary pulmonary hypertension","volume":"336","author":"Rubin","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2013.01.050_bib29","first-page":"81","article-title":"Prevention and reversal of hypoxic pulmonary hypertension by calcium antagonists","volume":"130","author":"Stanbrook","year":"1984","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ejphar.2013.01.050_bib30","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/00005344-199805000-00019","article-title":"Amlodipine inhibition of serum-, thrombin-, or fibroblast growth factor-induced vascular smooth-muscle cell proliferation","volume":"31","author":"Stepien","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.01.050_bib31","doi-asserted-by":"crossref","first-page":"79S","DOI":"10.1016\/S0167-5273(97)00244-1","article-title":"Amlodipine and vascular hypertrophy","volume":"62","author":"Stepien","year":"1997","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2013.01.050_bib32","first-page":"17","article-title":"Amlodipine inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension","volume":"91","author":"Takahashi","year":"1996","journal-title":"Res. Commun. Mol. Pathol. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.01.050_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/702836","article-title":"Novel approaches to treat experimental pulmonary arterial hypertension: a review","volume":"2010","author":"Umar","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.ejphar.2013.01.050_bib34","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(05)78495-6","article-title":"Attenuated K+ channel gene transcription in primary pulmonary hypertension","volume":"351","author":"Yuan","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2013.01.050_bib35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejphar.2012.05.043","article-title":"Benzenesulfonamide attenuates monocrotaline-induced pulmonary arterial hypertension in a rat model","volume":"5;690","author":"Zapata-Sudo","year":"2012","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913000708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913000708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:02:10Z","timestamp":1762142530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299913000708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":35,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0014299913000708"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.01.050","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel Ca\u00b2+ channel antagonist reverses cardiac hypertrophy and pulmonary arteriolar remodeling in experimental pulmonary hypertension","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.01.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}